Clinical meaningfulness of Alzheimer's Disease Assessment Scale–Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors-Reference-Cited by-同舟云学术

Clinical meaningfulness of Alzheimer's Disease Assessment Scale–Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors

Published:2017-03-21 Issue:10 Volume:13 Page:1098-1106
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Rockwood Kenneth¹²,Howlett Susan E.²³,Hoffman Deborah⁴,Schindler Rachel⁴,Mitnitski Arnold¹²

Affiliation:

1. DGI Clinical Inc. Halifax Nova Scotia Canada

2. Division of Geriatric Medicine Dalhousie University Halifax Nova Scotia Canada

3. Department of Pharmacology Dalhousie University Halifax Nova Scotia Canada

4. Pfizer Global Outcomes Research New London Connecticut USA

Funder

Dalhousie Medical Research Foundation

Atlantic Canada Opportunities Agency

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2017.02.005

Reference48 articles.

1. Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force

2. Efficacy and safety evaluation of HSD‐1 inhibitor ABT‐384 in Alzheimer's disease

3. Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease

4. A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

5. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force;The Journal of Prevention of Alzheimer's Disease;2024

2. Determining the Minimal Important Change of Everyday Functioning in Dementia;Neurology;2022-05-31

3. Patterns of Symptom Tracking by Caregivers and Patients With Dementia and Mild Cognitive Impairment: Cross-sectional Study;Journal of Medical Internet Research;2022-01-27

4. Efficacy and Safety of DL-3-n-Butylphthalide in the Treatment of Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2022-01-25

5. A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease;Acta Pharmaceutica Sinica B;2021-12